Key Takeaways

  • Menopause does not always resolve endometriosis. A small percentage of women still have active tissue after their periods stop, because endometriosis can produce its own estrogen independent of the ovaries.
  • Most women with an endometriosis history can take HRT safely. Both major reproductive medicine societies recommend combined estrogen and progesterone over estrogen-only therapy to limit the risk of tissue reactivation.
  • The recommendation for combined HRT applies even after a hysterectomy, because endometrial tissue can still survive outside the uterus and respond to estrogen.
  • If endometriosis symptoms return on HRT, stopping treatment is not the only option. Adjusting the dose, delivery method, or regimen type can often bring symptoms back under control.

If you have endometriosis, your doctor’s likely told you how sensitive the condition is to estrogen. But because the exact origins of endometriosis remain complex and multi-layered, facing perimenopause brings a distinct dilemma. When your doctor suggests hormone replacement therapy (HRT), it can feel counterintuitive to reintroduce the very hormone that you spent years trying to suppress. Without HRT, you may face menopause symptoms like hot flashes, poor sleep, or bone loss. But with it, you may worry you’re trading those symptoms for a recurrence of your endometriosis. 

But taking HRT with endometriosis isn’t the either-or situation it might seem. Evidence shows that most individuals with a history of endometriosis can use HRT safely. The key is choosing the right formulation. This guide explores how endometriosis behaves during and after menopause and the steps you and your doctor can take to manage your menopause symptoms.

Does endometriosis go away after menopause?

Endometriosis is a condition where tissue similar to the lining of your uterus grows outside of it on areas like your ovaries, fallopian tubes, or pelvic lining. That tissue feeds on estrogen. So when your ovaries slow down and eventually stop producing estrogen during menopause, most endometriosis tissue loses its fuel. For many women that brings relief: less pelvic pain and fewer heavy bleeding episodes.

However, menopause doesn’t always address the condition completely. Research estimates that roughly 2–5% of postmenopausal women still have active endometriosis. Part of the reason is that the tissue can produce its own estrogen through an enzyme called aromatase. This gives endometriosis a small fuel source even after your ovaries no longer produce the hormone. Deep patches of endometriosis are especially likely to persist because of this—with or without HRT. Reports of rare cases have even described new endometriosis appearing after menopause in women who never took hormone therapy.

What type of HRT is safest if you have endometriosis?

HRT delivers estrogen (and sometimes progesterone) to relieve menopause symptoms like hot flashes, night sweats, and vaginal dryness. However, that same estrogen causes uterine cells to grow, thickening your uterine lining and potentially stirring up inactive patches of endometriosis. To combat this overgrowth, many approaches add progesterone to slow the growth of endometriosis and thin out overgrowth of uterine tissue.

Several approaches allow you to get the benefits of HRT while keeping endometriosis tissue in check.

Combined HRT (estrogen and progesterone)

Progesterone slows the growth of endometriosis cells that estrogen stimulates. It also helps thin endometrial tissue out, making it less likely to become active again. For this reason, both the American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) recommend combined HRT as the standard hormone therapy for endometriosis patients. These guidelines apply even if you’ve had a hysterectomy, as endometrial tissue can still grow outside of the uterus.

Tibolone

This synthetic hormone breaks down into compounds with mild estrogen, progesterone, and testosterone effects. Because it provides its own progesterone-like activity, it achieves a similar balance to combined HRT but in a single pill. Tibolone is widely prescribed in Europe, Asia, and Australia. However, it’s not FDA approved for use in the United States. Researchers halted a large trial in 2006 after finding that tibolone doubled stroke risk in women over 70.

Hormonal IUD (Mirena®)

This birth control device physically sits in the uterus. It releases a steady, low dose of a progesterone-like hormone (levonorgestrel) directly into the surrounding tissue. In women with endometriosis, it delivers progesterone’s protective effect right where it’s needed most. It’s not a complete HRT, though; you may still need a separate source of estrogen to treat menopause symptoms.

Vaginal estrogen

If your main concern is vaginal dryness or pain during sex, consider a low-dose vaginal estrogen cream, ring, or tablet that delivers estrogen directly to the vaginal tissue. Very little reaches the rest of your body, so the risk of stirring up endometriosis elsewhere is low.This means it usually doesn’t require added progesterone.

What are the specific risks of HRT for women with endometriosis?

While combined HRT is the recommended approach for women with endometriosis, it doesn’t eliminate risk entirely. When discussing HRT, your provider will help you weigh two primary concerns: the potential for disease reactivation and the long-term health risks associated with estrogen use.

Reactivation of endometriosis

After a hysterectomy or surgery to remove visible lesions, microscopic amounts of endometriosis tissue can remain in the pelvic cavity. Because this tissue is estrogen-sensitive, the estrogen in HRT can wake it up and cause pain or inflammation.

This is significantly less common with combined HRT than with estrogen-only therapy. The added progesterone suppresses tissue growth, making combination therapy the standard choice for individuals with a uterus. Even so, this protective mechanism is why clinicians track outcomes so broadly. In a national survey of U.K. physicians, the majority reported seeing reactivation in fewer than 5% of women after hysterectomy and ovary removal.

Malignant transformations

In rare cases, endometriosis tissue can become cancerous, typically a type called clear cell or endometrioid carcinoma. The overall baseline risk of this happening is roughly 1% across all endometriosis cases. While that baseline rate remains low whether or not an individual uses HRT, different types of hormone therapy can still influence outcomes. A 2023 nationwide study of more than 20,000 postmenopausal women with endometriosis found that combined and tibolone-based HRT didn’t raise ovarian cancer risk, while estrogen-only HRT did.

Standard HRT risks

The general risks of HRT apply to women with endometriosis the same way they apply to anyone else. The level of risk depends heavily on the hormone delivery method. For example, oral estrogen pills carry a roughly 60% higher risk of blood clots than transdermal options like patches or pills because estrogen directly passes through the liver. This prompts the liver to produce higher levels of clotting proteins. Combination HRT leads to a small cumulative increase in breast cancer risk after five years of continuous use, while estrogen-only therapy lowers breast cancer risk

The body’s response to early estrogen loss

For women who enter menopause early—whether through hysterectomy or endometriosis medicationestrogen loss is sudden. And surgery or endometriosis medication side effects like hot flashes and vaginal dryness are often intense. This rapid decline can speed up long-term health risks, making HRT necessary for protection until at least the average age of natural menopause (around 51). 

To understand why hormonal support matters, it helps to look at what estrogen does for your body, as well as how providers handle endometriosis symptom recurrence.

Long-term effects of estrogen decline

Without estrogen, your body faces significant challenges, including:

  • Bone loss: Estrogen balances the cells that build bone (osteoblasts) and break down old bone (osteoclasts). Without estrogen, bone formation can’t keep pace with resorption, leading to density loss.
  • Cardiovascular risk: Estrogen increases good cholesterol (HDL) and decreases bad cholesterol (LDL). It also binds to receptors in the lining of your blood vessels to help them relax and dilate for better blood pressure management. A sudden drop unbalances cholesterol and increases the risk of blood vessel rigidity and heart disease.
  • Cognitive decline: Estrogen helps neurons transport and use glucose efficiently. It also promotes growth and connection between neurons (neuroplasticity). When levels decline, you may experience brain fog and fatigue.

What to do if endometriosis symptoms come back

It’s important to watch for any signs that your endometriosis may be responding to the estrogen in your HRT. This could include new pelvic pain, unexpected bleeding, or changes in bowel or bladder function. 

If symptoms do come back, you don’t have to stop HRT altogether. Your provider can adjust the dose or switch the treatment type. They can also move you from a cyclical to a continuous regimen or change the route of hormone delivery. However, if HRT isn't the right fit even after adjustments, your doctor will work with you to find an alternative. Hormonal treatment isn't right for everyone.

Navigating HRT with endometriosis through Maven Clinic

Choosing HRT with an endometriosis history involves more variables than standard menopause care. Your surgical history, the type and locations of the disease, and your long-term health goals all matter. You deserve a provider who specializes in the intersection of endometriosis and menopause care.

Maven Clinic’s Hormone Care program connects you with a menopause specialist who can work through that complexity with you. During your first visit, your provider will cover your full health history to help you choose the safest hormone types and delivery methods. From there, they’ll build a personalized plan, monitor your progress, and adjust your treatment as needed to keep you feeling your best.

Connect with a Maven Clinic specialist to find the safest, most effective HRT approach for you.

No items found.

FAQ

Can I take HRT with endometriosis?

Yes. Most women with an endometriosis history can use HRT safely. Both the ASRM and the ESHRE support this. These organizations recommend combined formulations over estrogen-only to limit tissue growth. The key is working with a provider who understands your history and can choose the formulation, dose, and delivery method that fits your profile.

Can HRT make endometriosis come back?

It’s possible but uncommon. Most reports of endometriosis returning on HRT involve estrogen-only formulations. That’s one reason guidelines recommend combined HRT for women with this history. With combined formulations, the progesterone component works against estrogen’s effect on dormant endometriosis tissue, keeping the risk low.

Can HRT help with endometriosis? 

HRT doesn’t treat endometriosis itself. But when endometriosis medication or a hysterectomy pushes you into early menopause, HRT can help manage the consequences. It reduces hot flashes, vaginal dryness, and the long-term cardiovascular and cognitive risks that come with losing estrogen’s support ahead of schedule.

Table of Contents

Maven Consumer

The right choice is different for everyone. Let's find yours.

Maven's hormone specialists walk you through every treatment option and recommend the one that best fits your body and lifestyle.

Find your best option

Get the care this chapter actually deserves

Start your assessment